PTAB To Review Hair Loss Treatment Patent After Rehearing
Six months after deciding not to review a Concert Pharmaceuticals Inc. patent related to a potential hair loss treatment, the Patent Trial and Appeal Board reversed course Monday and said Incyte...To view the full article, register now.
Already a subscriber? Click here to view full article